A PHASE 3, EFFICACY AND SAFETY STUDY OF ORAL PALOVAROTENE FOR THE TREATMENT OF FIBRODYSPLASIA OSSIFICANS PROGRESSIVA (FOP

Registry ID

PVO-1A-301

Source registry

HEALTH_CANADA

Status

Closed

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

CLEMENTIA PHARMACEUTICALS INC.

Start date

2019-08-06

Completion date

2022-07-26

Last update

2017-11-08

Conditions

• FIBRODYSPLASIA OSSIFICANS PROGRESSIVA (FOP)

Related clinical trials

• A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF INCB000928 IN PARTICIPANTS WITH FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

View on source registry